AVALYN PHARMACEUTICALS INC (AVLN): Ownership & Insider Activity

Hedge funds and institutional managers reporting a position in AVLN. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
11
13F filers
Aggregate Value
$56.8M
Across holders
Last Price
$28.13
2026-10-02
Sector
—
GICS
Quarterly fund activity11 increased0 reduced0 exited
Institutional Holders of AVLN
↗
11 holders
Manager⇅Type⇅Shares⇅Market Value▼% of Total⇅% of Portfolio⇅Action⇅QoQ Change⇅Quarter⇅
CITADEL ADVISORS LLC
CIK 0001423053
Hedge Fund959K$31.6M55.6%0.0%Added—Q2 2026
BAKER BROS. ADVISORS LP
CIK 0001263508
Hedge Fund350K$11.5M20.3%0.1%Added—Q2 2026
Woodline Partners LP
CIK 0001784547
Hedge Fund151K$5.0M8.8%0.0%Added—Q2 2026
MOORE CAPITAL MANAGEMENT, LP
CIK 0001448574
Hedge Fund110K$3.6M6.4%0.1%Added—Q2 2026
Brevan Howard Capital Management LP
CIK 0001512857
Hedge Fund43K$1.4M2.5%0.0%Added—Q2 2026
BALYASNY ASSET MANAGEMENT LLC
CIK 0001218710
Hedge Fund34K$1.1M2.0%0.0%Added—Q2 2026
Davidson Kempner Capital Management LP
CIK 0001595082
Hedge Fund23K$757K1.3%0.0%Added—Q2 2026
SHAW D E & CO INC
CIK 0001009207
Hedge Fund23K$757K1.3%0.0%Added—Q2 2026
Hudson Bay Capital Management LP
CIK 0001393825
Hedge Fund14K$467K0.8%0.0%Added—Q2 2026
SOROS FUND MANAGEMENT LLC
CIK 0001029160
Family Office10K$329K0.6%0.0%Added—Q2 2026
1–10 of 11
1 / 2
Loading recent insider activity…